JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 13, 2004; DOI: 10.1124/jpet.104.067835


0022-3565/04/3103-1216-1225$20.00
JPET 310:1216-1225, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.067835v1
310/3/1216    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reynolds, J. L.
Right arrow Articles by Spengler, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reynolds, J. L.
Right arrow Articles by Spengler, R. N.

NEUROPHARMACOLOGY

Brain-Derived Tumor Necrosis Factor-{alpha} and Its Involvement in Noradrenergic Neuron Functioning Involved in the Mechanism of Action of an Antidepressant

Jessica L. Reynolds, Tracey A. Ignatowski, Reeteka Sud, and Robert N. Spengler

Department of Pathology and Anatomical Sciences, State University of New York, Buffalo, New York

The present study documents a role for brain-derived tumor necrosis factor-{alpha} (TNF) in the mechanism of action of the antidepressant drug desmethylimipramine (desipramine). To establish this role, field stimulation and superfusion of rat hippocampal slices was employed to investigate the regulation of norepinephrine (NE) release by TNF. Chronic desipramine administration transforms TNF-mediated inhibition of NE release to facilitation, dependent upon {alpha}2-adrenergic receptor activation. Chronic i.c.v. microinfusion of polyclonal TNF antibody (pTNF-Ab) similarly transforms TNF inhibition of NE release to facilitation. To determine whether this transformation is due to desipramine-induced inhibition of TNF bioactivity in the brain, rats were i.c.v. microinfused with recombinant rat TNF (rrTNF) for 14 days, either alone or with simultaneous i.p. desipramine administration. TNF regulation of NE release in hippocampal slices isolated from these rats was compared with slices isolated from rats chronically administered desipramine alone. Although simultaneous microinfusion of rrTNF with chronic desipramine administration prevents the transformation induced by desipramine, microinfusion of rrTNF enhances TNF inhibition of NE release. These cellular events correspond to changes in immobility, analyzed by the forced swim test (FST). Intracerebroventricular microinfusion of rrTNF increases the duration of immobility of rats in the FST, compared with rats microinfused with aCSF. Desipramine administered chronically decreases immobility duration, which is mimicked by i.c.v. microinfusion of pTNF-Ab and prevented by simultaneous i.c.v. microinfusion of rrTNF. Thus, i.c.v. microinfusion of rrTNF with concomitant desipramine administration opposes decreases in neuron-associated TNF levels, required to transform presynaptic sensitivity to TNF, which is necessary for the drug to be efficacious.


Received March 1, 2004; accepted April 12, 2004.

Address correspondence to: Dr. Robert N. Spengler, University at Buffalo, The State University of New York, Department of Pathology and Anatomical Sciences, 206 Farber Hall, 3435 Main Street, Buffalo, New York 14214. E-mail: spengler{at}buffalo.edu




This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. A. Galic, K. Riazi, J. G. Heida, A. Mouihate, N. M. Fournier, S. J. Spencer, L. E. Kalynchuk, G. C. Teskey, and Q. J. Pittman
Postnatal Inflammation Increases Seizure Susceptibility in Adult Rats
J. Neurosci., July 2, 2008; 28(27): 6904 - 6913.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.